FRA:SYAB - Deutsche Boerse Ag - DE000A2TSL71 - Common Stock - Currency: EUR
FRA:SYAB (7/12/2024, 7:00:00 PM)
11.06
-0.02 (-0.18%)
The current stock price of SYAB.DE is 11.06 EUR. In the past month the price decreased by -0.18%. In the past year, price increased by 23.37%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CVS.DE | CVS HEALTH CORP | 9.74 | 69.83B | ||
FME.DE | FRESENIUS MEDICAL CARE AG | 18.23 | 30.16B | ||
FRE.DE | FRESENIUS SE & CO KGAA | 16.96 | 24.26B | ||
V3V.DE | FAMICORD AG | 28.43 | 70.21M | ||
HI.MI | HEALTH ITALIA SPA | 8.84 | 23.56M |
Synlab AG engages in the provision of clinical laboratory and medical diagnostic services. The company is headquartered in Muenchen, Bayern and currently employs 27,047 full-time employees. The company went IPO on 2021-04-30. The firm is engaged in laboratory services for human and veterinary medicine, as well as environmental analysis.
SYNLAB AG
Moosacher Strasse 88
Muenchen BAYERN DE
Employees: 27047
Phone: 49893076020
The current stock price of SYAB.DE is 11.06 EUR. The price decreased by -0.18% in the last trading session.
The exchange symbol of SYNLAB AG is SYAB and it is listed on the Deutsche Boerse Ag exchange.
SYAB.DE stock is listed on the Deutsche Boerse Ag exchange.
9 analysts have analysed SYAB.DE and the average price target is 13.6 EUR. This implies a price increase of 22.97% is expected in the next year compared to the current price of 11.06. Check the SYNLAB AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SYNLAB AG (SYAB.DE) has a market capitalization of 2.43B EUR. This makes SYAB.DE a Mid Cap stock.
SYNLAB AG (SYAB.DE) currently has 27047 employees.
SYNLAB AG (SYAB.DE) has a support level at 10.62 and a resistance level at 11.08. Check the full technical report for a detailed analysis of SYAB.DE support and resistance levels.
The Revenue of SYNLAB AG (SYAB.DE) is expected to grow by 1.55% in the next year. Check the estimates tab for more information on the SYAB.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SYNLAB AG (SYAB.DE) has a dividend yield of 2.91%. The yearly dividend amount is currently 0.35. Check the full fundamental report for a detailed analysis of SYAB.DE dividend history, reliability and sustainability.
SYNLAB AG (SYAB.DE) will report earnings on 2024-08-08.
The PE ratio for SYNLAB AG (SYAB.DE) is 27.65. This is based on the reported non-GAAP earnings per share of 0.4 and the current share price of 11.06 EUR. Check the full fundamental report for a full analysis of the valuation metrics for SYAB.DE.
ChartMill assigns a technical rating of 6 / 10 to SYAB.DE. When comparing the yearly performance of all stocks, SYAB.DE is one of the better performing stocks in the market, outperforming 77.92% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to SYAB.DE. Both the profitability and the financial health of SYAB.DE get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months SYAB.DE reported a non-GAAP Earnings per Share(EPS) of 0.4. The EPS increased by 338.87% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 3.42% | ||
ROA | 1.9% | ||
ROE | 3.77% | ||
Debt/Equity | 0.59 |
ChartMill assigns a Buy % Consensus number of 78% to SYAB.DE. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -36.39% and a revenue growth 1.55% for SYAB.DE